Damien Gerald

1.9k total citations
16 papers, 1.5k citations indexed

About

Damien Gerald is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Damien Gerald has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Damien Gerald's work include Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Damien Gerald is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Damien Gerald collaborates with scholars based in United States, France and Australia. Damien Gerald's co-authors include Fatima Mechta‐Grigoriou, Moshé Yaniv, Laura E. Benjamin, Denise A. Chan, Amato J. Giaccia, Yves‐Michel Frapart, Edurne Berra, Jacques Pouysségur, Daniel Mansuy and Sudhakar Chintharlapalli and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Damien Gerald

16 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Damien Gerald United States	10	973	553	376	205	130	16	1.5k
Wendy W. Hwang‐Verslues Taiwan	17	818 0.8×	424 0.8×	546 1.5×	195 1.0×	87 0.7×	22	1.4k
Ànna Manzano Spain	22	1.2k 1.2×	876 1.6×	263 0.7×	166 0.8×	129 1.0×	41	1.8k
Lydia W.T. Cheung Hong Kong	20	987 1.0×	332 0.6×	348 0.9×	168 0.8×	116 0.9×	40	1.6k
Alexander Valent France	18	962 1.0×	572 1.0×	659 1.8×	271 1.3×	216 1.7×	41	1.9k
Rosana Meyer United States	23	1.1k 1.1×	220 0.4×	308 0.8×	187 0.9×	177 1.4×	37	1.4k
Sandra Cascio United States	21	917 0.9×	487 0.9×	405 1.1×	216 1.1×	56 0.4×	41	1.7k
V. Poulaki United States	17	735 0.8×	291 0.5×	300 0.8×	197 1.0×	64 0.5×	34	1.3k
Xiliang Zha China	26	1.1k 1.2×	292 0.5×	273 0.7×	242 1.2×	258 2.0×	78	1.8k
Suyoun Chung Japan	20	944 1.0×	449 0.8×	214 0.6×	147 0.7×	171 1.3×	27	1.5k
Giuseppina De Petro Italy	25	1.1k 1.1×	1.0k 1.8×	236 0.6×	91 0.4×	115 0.9×	65	1.8k

Countries citing papers authored by Damien Gerald

Since Specialization

Citations

This map shows the geographic impact of Damien Gerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Gerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Gerald more than expected).

Fields of papers citing papers by Damien Gerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Gerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Gerald. The network helps show where Damien Gerald may publish in the future.

Co-authorship network of co-authors of Damien Gerald

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Gerald. A scholar is included among the top collaborators of Damien Gerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Gerald. Damien Gerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wu, Bill X., Hakan Çam, Chelsea Bolyard, et al.. (2025). Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma. Neuro-Oncology. 27(12). 3087–3103. 1 indexed citations

Fischl, Anthony S., Xiaoen Wang, Beverly L. Falcón, et al.. (2019). Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition. Molecular Cancer Therapeutics. 18(4). 856–867. 16 indexed citations

Bravo‐Nuevo, Arturo, et al.. (2018). RhoB antibody alters retinal vascularization in models of murine retinopathy. Journal of Cellular Biochemistry. 120(6). 9381–9391. 5 indexed citations

Chintharlapalli, Sudhakar, Johnny E. Croy, Donmienne Leung, et al.. (2016). Abstract 3259: LY3127804, a novel anti-Angiopoietin-2 antibody in combination with an anti-VEGFR2 antibody potently inhibits angiogenesis, tumor growth and metastasis. Cancer Research. 76(14_Supplement). 3259–3259. 1 indexed citations

Phung, Thuy L., Wa Du, Qi Xue, et al.. (2014). Akt1 and Akt3 Exert Opposing Roles in the Regulation of Vascular Tumor Growth. Cancer Research. 75(1). 40–50. 40 indexed citations

Du, Wa, Damien Gerald, Carole Perruzzi, et al.. (2013). Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin. Laboratory Investigation. 93(10). 1115–1127. 31 indexed citations

Gerald, Damien, Irit Adini, Sharon Shechter, et al.. (2013). RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription. Nature Communications. 4(1). 2824–2824. 51 indexed citations

Gerald, Damien, Sudhakar Chintharlapalli, Hellmut G. Augustin, & Laura E. Benjamin. (2013). Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy. Cancer Research. 73(6). 1649–1657. 168 indexed citations

Kazerounian, Shiva, Damien Gerald, Minzhou Huang, et al.. (2012). RhoB Differentially Controls Akt Function in Tumor Cells and Stromal Endothelial Cells during Breast Tumorigenesis. Cancer Research. 73(1). 50–61. 40 indexed citations

10.

Nucera, Carmelo, Alessandro Porrello, Zeus A. Antonello, et al.. (2010). B-Raf ^V600E and thrombospondin-1 promote thyroid cancer progression. Proceedings of the National Academy of Sciences. 107(23). 10649–10654. 149 indexed citations

11.

Toullec, Aurore, Damien Gerald, Gilles Despouy, et al.. (2010). Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Molecular Medicine. 2(6). 211–230. 259 indexed citations

12.

Toullec, Aurore, Damien Gerald, Gilles Despouy, et al.. (2010). 225 Oxidative stress promotes myofibroblast differentiation and tumour spreading. European Journal of Cancer Supplements. 8(3). 124–124. 9 indexed citations

13.

Gerald, Damien, et al.. (2006). PD-07.06. Urology. 68. 25–26. 1 indexed citations

14.

Gerald, Damien, Edurne Berra, Yves‐Michel Frapart, et al.. (2004). JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress. Cell. 118(6). 781–794. 471 indexed citations

15.

Mechta‐Grigoriou, Fatima, Damien Gerald, & Moshé Yaniv. (2001). The mammalian Jun proteins: redundancy and specificity. Oncogene. 20(19). 2378–2389. 286 indexed citations

16.

Gerald, Damien, et al.. (1976). [The risk of cardiac arrest during laparoscopy. A study of 50,000 laparoscopies and animal experimentation].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(7). 925–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact